FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1612664998> ?p ?o ?g. }

• W1612664998 abstract "Abstract Abstract 1307 Poster Board I-329 A 44 years old woman presented with metrorrhagia. Coagulation tests revealed a prolongation of activated partial thromboplastin time up to 77 seconds (control 33 seconds) which could not be corrected by mixing with normal plasma. The factor VIII activity level was reduced to 0.06 IU/mL. The Bethesda assay demonstrated the presence of a factor VIII inhibitor at 29 Bethesda units per ml (BU/mL). Other coagulations studies were within the normal ranges. Serum protein electrophoresis revealed a monoclonal band in the gamma region. IgA kappa monoclonal gammopathy was confirmed by immunofixation. The concentration of IgA kappa was 2.1 g/L. The haemoglobin level was 13.1 g/dL, creatininemia 80 μmol/L and calcemia 2.38 mmol/L. Standard bone X Rays and MRI of spine showed no lytic bone lesions. Bone marrow aspiration showed 11% plasma cell infiltration. A diagnosis of IgA kappa smoldering multiple myeloma associated with acquired hemophilia was made. The patient initially received four Rituximab infusions without significant effect. Several episodes of moderate uterine bleedings were treated with recombinant activated Factor VII infusions. It is noteworthy that she never had any other bleeding. Finally, electrocoagulation of endometrium definitively stopped metrorrhagia despite persistence of factor VIII inhibitor activity. Given that the acquired haemophilia was no longer symptomatic and that there were no other complications associated with multiple myeloma no specific treatment of multiple myeloma was proposed. To investigate the link between the IgA kappa smoldering myeloma and the factor VIII inhibitor activity, polyclonal antibodies that are specific for IgA kappa or IgA lambda were used ex vivo. These antibodies target unique conformational epitopes located at the junctions of heavy chains and light chains of immunoglobulins (Binding Site Group Ltd). Bethesda assay was performed on patient's plasma diluted at 1/30 (patient's monoclonal IgA kappa final concentration: 0.07 g/L) mixed with either anti IgA kappa or anti IgA lambda antibodies (final concentration: 2.5 g/L). The anti factor VIII activity was decreased with addition of anti IgA kappa antibody (7.2 UB/ml) but not with anti IgA lambda antibodies (24 UB/ml). We confirmed these results by using a Polyethyleneglycol (PEG) precipitation step. Patient's plasma was mixed with anti IgA Kappa antibodies (final concentration 9.2 g/L) and PEG (3%). After centrifugation, the anti factor VIII inhibitor activity in supernatant was totally suppressed ( Acquired hemophilia is a rare autoimmune disorder in which the patients develop an autoantibody directed against coagulation factor VIII leading to a clinically significant bleeding diathesis. In 50% of the cases there is no detectable underlying disease; however in 10% of cases there is an association with an underlying malignancy, either solid or haematological. Concurrent acquired hemophilia and monoclonal gammopathy is rare and few reports have associated monoclonal proteins to factor VIII inhibition but without any in vitro confirmation. In this report, we described a case of an IgA kappa smoldering myeloma patient who presented with an acquired haemophilia and demonstrated that the IgA monoclonal protein was acting as the factor VIII inhibitor. A broad range of autoimmune phenomena frequently complicate hematologic malignancies and acquired hemophilia is considered to be the consequence of immune deregulation with usually oligoclonal anti-Factor VIII profile. Understanding of the underlying pathogenic mechanisms responsible for the acquired haemophilia could help to optimize treatment management. To the best of our knowledge, this is the first report of multiple myeloma associated acquired hemophilia with demonstration that monoclonal gammopathy could be responsible of factor VIII inhibitor activity. Disclosures Harding: The Binding Site Group Ltd: Employment. Bradwell: The Binding Site Group Ltd: Chairman." @default.
• W1612664998 created "2016-06-24" @default.
• W1612664998 creator A5008872919 @default.
• W1612664998 creator A5022435450 @default.
• W1612664998 creator A5033498204 @default.
• W1612664998 creator A5052180973 @default.
• W1612664998 creator A5052650117 @default.
• W1612664998 creator A5057466651 @default.
• W1612664998 creator A5090219021 @default.
• W1612664998 date "2010-03-31" @default.
• W1612664998 modified "2023-09-27" @default.
• W1612664998 title "Acquired hemophilia associated with smoldering myeloma: demonstration that the monoclonal gammopathy acts as the factor VIII inhibitor" @default.
• W1612664998 doi "https://doi.org/10.7490/f1000research.142.1" @default.
• W1612664998 hasPublicationYear "2010" @default.
• W1612664998 type Work @default.
• W1612664998 sameAs 1612664998 @default.
• W1612664998 citedByCount "0" @default.
• W1612664998 crossrefType "journal-article" @default.
• W1612664998 hasAuthorship W1612664998A5008872919 @default.
• W1612664998 hasAuthorship W1612664998A5022435450 @default.
• W1612664998 hasAuthorship W1612664998A5033498204 @default.
• W1612664998 hasAuthorship W1612664998A5052180973 @default.
• W1612664998 hasAuthorship W1612664998A5052650117 @default.
• W1612664998 hasAuthorship W1612664998A5057466651 @default.
• W1612664998 hasAuthorship W1612664998A5090219021 @default.
• W1612664998 hasConcept C126322002 @default.
• W1612664998 hasConcept C142724271 @default.
• W1612664998 hasConcept C159654299 @default.
• W1612664998 hasConcept C163864487 @default.
• W1612664998 hasConcept C203014093 @default.
• W1612664998 hasConcept C2776364478 @default.
• W1612664998 hasConcept C2776855637 @default.
• W1612664998 hasConcept C2778261982 @default.
• W1612664998 hasConcept C2778382381 @default.
• W1612664998 hasConcept C2779936836 @default.
• W1612664998 hasConcept C2780007613 @default.
• W1612664998 hasConcept C542903549 @default.
• W1612664998 hasConcept C71924100 @default.
• W1612664998 hasConcept C90924648 @default.
• W1612664998 hasConceptScore W1612664998C126322002 @default.
• W1612664998 hasConceptScore W1612664998C142724271 @default.
• W1612664998 hasConceptScore W1612664998C159654299 @default.
• W1612664998 hasConceptScore W1612664998C163864487 @default.
• W1612664998 hasConceptScore W1612664998C203014093 @default.
• W1612664998 hasConceptScore W1612664998C2776364478 @default.
• W1612664998 hasConceptScore W1612664998C2776855637 @default.
• W1612664998 hasConceptScore W1612664998C2778261982 @default.
• W1612664998 hasConceptScore W1612664998C2778382381 @default.
• W1612664998 hasConceptScore W1612664998C2779936836 @default.
• W1612664998 hasConceptScore W1612664998C2780007613 @default.
• W1612664998 hasConceptScore W1612664998C542903549 @default.
• W1612664998 hasConceptScore W1612664998C71924100 @default.
• W1612664998 hasConceptScore W1612664998C90924648 @default.
• W1612664998 hasLocation W16126649981 @default.
• W1612664998 hasOpenAccess W1612664998 @default.
• W1612664998 hasPrimaryLocation W16126649981 @default.
• W1612664998 hasRelatedWork W100766839 @default.
• W1612664998 hasRelatedWork W1975751800 @default.
• W1612664998 hasRelatedWork W1981590923 @default.
• W1612664998 hasRelatedWork W1985274531 @default.
• W1612664998 hasRelatedWork W1997640145 @default.
• W1612664998 hasRelatedWork W2006042065 @default.
• W1612664998 hasRelatedWork W2008365695 @default.
• W1612664998 hasRelatedWork W2024228520 @default.
• W1612664998 hasRelatedWork W2035820290 @default.
• W1612664998 hasRelatedWork W2088059866 @default.
• W1612664998 hasRelatedWork W2090789376 @default.
• W1612664998 hasRelatedWork W2117391654 @default.
• W1612664998 hasRelatedWork W2122507029 @default.
• W1612664998 hasRelatedWork W2128653791 @default.
• W1612664998 hasRelatedWork W2164943057 @default.
• W1612664998 hasRelatedWork W2409839984 @default.
• W1612664998 hasRelatedWork W2801836244 @default.
• W1612664998 hasRelatedWork W2943920857 @default.
• W1612664998 hasRelatedWork W3206922288 @default.
• W1612664998 hasRelatedWork W5358573 @default.
• W1612664998 hasVolume "1" @default.
• W1612664998 isParatext "false" @default.
• W1612664998 isRetracted "false" @default.
• W1612664998 magId "1612664998" @default.
• W1612664998 workType "article" @default.